Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

NCT00061035 is registered in ClinicalTrials.gov with Cosmo Bioscience as lead sponsor.

NCT NCT00061035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00061035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma
Lead sponsor
Cosmo Bioscience
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2003
Completion date
Not reported
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms